[e-farmacos] Mejorando el acceso y uso de medicamentos psicotropicos

["Canas, Martin" <macanas@netverk.com.ar>]

Estimadas y estimados,

Esta disponible en la red el informe

Improving Access and Use of Psychotropic Medicines
Mental Health Policy and Service Guidance Package
World Health Organization, 2004

"...los medicamentos psicotropicos son tratamientos eficaces para los trastornos mentales cuando son utilizadas conjuntamente con intervenciones psicosociales.

La atencion a la seleccion racional de medicamentos, a la asequibilidad,
al financiamiento sostenible y a la disponibilidad de sistemas de salud
y de aprovisionamiento confiables aseguraran  que estos tratamientos
esten disponibles para aquellos que los necesiten..."

El documento pesa 500 kb y la direccion es:

http://www.who.int/medicines/library/theme/Improving_Access_Use_Psychotro
pic_Medicine.pdf

Felicitaciones a Dolors y a Emilio por su participacion en tan valioso documento!

Saludos,

Martin

Martin Canas
La Plata (Argentina)
La tabla de contenidos es la siguiente

Executive summary 2

Aims and target audience 10

Abbreviations 11

1. Introduction 12

2. Improving access to psychotropics 16

2.1 Making access an integral part of a mental health policy 17

2.2 Legislation supporting access 18

2.3 International trade agreements and access 19

2.4 Selecting the most needed psychotropics 20

2.5 Maximizing affordability of psychotropics 23

2.6 Ensuring sustainable financing 27

2.7 Improving distribution strategies and safeguarding quality 28

3. Promoting appropriate use of psychotropics 30

3.1 Factors underlying inappropriate use of medicines 30

3.2 Investigating the use of medicines 32

3.3 Improving the use of medicines 33

3.4 Examples of educational strategies 35

3.5 Examples of managerial strategies 36

3.6 Examples of regulatory strategies 37

3.7 Promoting appropriate use in the private sector 37

3.8 Making available unbiased information on medicines 38

4. Assessing a psychotropic access system 40

5. A seven-step approach to improving access to psychotropics 45

Annex 1. Examples of treatment for disorders, including their pharmacological effectiveness 48